Author:
Baker Cheryl H.,Kedar Daniel,McCarty Marya F.,Tsan Rachel,Weber Kristen L.,Bucana Corazon D.,Fidler Isaiah J.
Subject
Pathology and Forensic Medicine
Reference41 articles.
1. Preclinical profile of PKI 166—a novel and potent EGF-R tyrosine kinase inhibitor for clinical development;Traxler;Clin Cancer Res,1999
2. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma;Bruns;Cancer Res,2000
3. Optimization for the blockade of the epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma;Solorzano;Clin Cancer Res,2001
4. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal;Benjamin;J Clin Invest,1999
5. Conditioned switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal;Benjamin;Proc Natl Acad Sci USA,1997
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献